Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid for Reducing BCG Toxicity in NMIBC
NCT02207608Phase 2Completed
- Sponsor
- University of Rome Tor Vergata
- Start
- Sep 2011
- Primary completion
- Aug 2012
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of hyaluronic acid in cystitis, sponsored by University of Rome Tor Vergata. Started Sep 2011; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT02207608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02207608.